Neurocrine Biosciences

We were honored to host high school students from?Ocean Discovery Institute at our San Diego HQ. During their time on campus, they learned about Neurocrine, toured our state-of-the-art laboratories, and explored the various job roles and career paths of Neurocrine employees. We are proud to support the next generation of science leaders!

#FromInternToFullTime: Meet?Nikhil Madan! When Nikhil joined Neurocrine as a summer intern, he was unsure of what direction he wanted to take in his career. His internship with the Business Development team combined his passion for the life sciences with his strategic thinking capabilities. 4.5 years later, Nikhil is a valued member of the team and company. https://lnkd.in/gkQhXDFG

Happy Employee Appreciation Day to our team at Neurocrine! Your hard work, dedication, and passion drive our success every day. Thank you for all that you do. #EmployeeAppreciationDay

We are thrilled to introduce you to our newest board members at California Life Sciences! ?? Jane Grogan, Ph.D. is Executive Vice President and Head of Research at Biogen. Dr. Grogan joined Biogen in 2023, bringing nearly two decades of experience leading biotech research, including fifteen years with Genentech. Dr. Grogan most recently served as the Chief Scientific Officer at Graphite Bio and ArsenalBio, both cell and gene therapy companies. ?? Matt Abernethy, Chief Financial Officer at Neurocrine Biosciences. Matt is responsible for leading corporate finance activities, commercial supply chain operations, information technology, investor relations, facilities, and European operations at Neurocrine Biosciences. ?? Sarah Huoh, Corporate Vice President, Public Affairs at Edwards Lifesciences. With more than 20 years of experience in medical technology and healthcare, she has successfully led numerous high-profile initiatives and engagements, supporting and enhancing company reputations through strategic global stakeholder engagement. ?? Alice Valder Curran, Partner at Hogan Lovells. Alice Valder Curran advises pharmaceutical manufacturers on drug pricing matters, with emphasis on the Medicaid Drug Rebate Program, the Medicare average sales price (ASP) reporting requirement, the Health Resources and Services Administration (HRSA) 340B Drug Pricing Program, and the recently enacted Inflation Reduction Act (IRA). Welcome to the team, Jane, Matthew, Sarah and Alice! #WeAreCALifeSciences #BoardMembers

Today we announced the initiation of a Phase 1 clinical study evaluating NBI-1140675, an investigational, oral, selective second-generation VMAT2 inhibitor in development for the potential treatment of certain neurological and neuropsychiatric conditions. Read more: https://lnkd.in/gD4s8urM

Today, on Rare Disease Day, we stand in solidarity with the one in 10 people living with a rare disease. Your strength and resilience inspire us every day.?We also honor the caregivers whose unwavering support makes all the difference. #RareDiseaseDay #ShowYourRare

Today we announced top-line data from a Phase 4 study, KINECT-PRO?, which is the first study designed to evaluate patient-reported impact of TD treatment with a VMAT2 inhibitor using multiple clinically validated scales, focusing on improvement in functionality and quality of life measures. Read more: https://lnkd.in/gHUnpGUB

We are proud to partner with Chelsea Roberts to highlight “More Than HD,” an educational initiative created to empower individuals navigating their journey with Huntington’s disease and symptoms including Huntington’s disease chorea. Chelsea is a dedicated advocate in the HD community, having lost her mother to the disease, and we are pleased to have her share information about More Than HD to people living with HD and caregivers who may need it most. Explore the More Than HD website: https://lnkd.in/gam6KEqz #MoreThanHD #ad #sponsorship #PaidPartnership

We are capping off Black History Month with an on-campus event honoring the achievements and contributions of Black Americans throughout history.?

#FromInternToFullTime: Meet?Ally Jensen, who started at Neurocrine as an intern and is now a valued, full-time team member! Not only has Ally made a huge impact on the Corporate Communications group, she also has taken advantage of our Education Assistance Program. This program is just one of the many ways we support our employees in their professional development and career journeys.?https://lnkd.in/gkQhXDFG